Blog

• 
• 
• 
• 

There have been 12 U.S. Patents issued in FY20. Here are the U.S. Patents issued in August:

A groundbreaking study, using data from NASA and a technique pioneered by a Vanderbilt professor, is giving humankind a glimpse at a distant exoplanet with a size similar to Earth and a surface which may resemble Mercury or Earth’s Moon.

DDR1 is a receptor tyrosine kinase (RTK) — a cell surface receptor — that regulates multiple functions including the maintenance of the normal structure of tissues, but which also contributes to pathological conditions including cancer, inflammation and fibrosis.

There have been 6 U.S. Patents issued in FY20. Here are the U.S. Patents issued in July:

Michael Savona, MD, professor of Medicine and Cancer Biology, and director of Hematology Research at Vanderbilt- Ingram Cancer Center, has received a competitive grant award from the Edward P. Evans Foundation.

The Discovery Research Grant (DRG) will support his work to develop therapies for patients with myelodysplastic syndromes, a group of cancers that occur when immature blood cells in the bone marrow don’t fully develop or fail to become healthy blood cells.

The Vanderbilt Center for Immunobiology (VCI) has relaunched its mission with a greater focus on human immunology, an endeavor supported by additional researchers, more funding support and designation as a Center of Excellence.

Using mouse skin as a model system, J. Scott Beeler, Jennifer Pietenpol, PhD, and colleagues found that p73 is required for the timely healing of cutaneous wounds. In normal tissue, p73 expression increased in response to wounding, whereas p73 deficiency resulted in delayed wound healing, they reported in the journal PLOS ONE.